Nanobiosensors: Role in cancer detection and diagnosis

Andrew Gdowski, Amalendu Prakash Ranjan, Anindita Mukerjee, Jamboor K. Vishwanatha

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality. Nanosized components incorporated into existing clinical diagnostic and detection systems as well as novel nanobiosensors have demonstrated improved sensitivity and specificity compared with traditional cancer testing approaches. Nanoparticles, nanowires, nanotubes, and nanocantilevers are examples of four nanobiosensor systems that have been used experimentally in the context of detection and diagnosis of prostate, breast, pancreatic, lung, and brain cancers over the past few years. Nanobiosensors will begin to transition into clinically validated tests as experimental and engineering techniques advance. This paper presents examples of some such nanobiosensors for cancer diagnosis and detection.

Original languageEnglish
Pages (from-to)33-58
Number of pages26
JournalAdvances in Experimental Medicine and Biology
Volume807
DOIs
StatePublished - 1 Jan 2014

Fingerprint

Nanocantilevers
Nanowires
Nanotubes
Brain
Neoplasms
Nanoparticles
Pancreatic Neoplasms
Brain Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Testing
Breast Neoplasms
Morbidity
Sensitivity and Specificity
Mortality

Keywords

  • Cancer detection and diagnosis
  • Nanobiosensors

Cite this

@article{b9c7e63c6e3049c3bc7ce5e69d027199,
title = "Nanobiosensors: Role in cancer detection and diagnosis",
abstract = "The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality. Nanosized components incorporated into existing clinical diagnostic and detection systems as well as novel nanobiosensors have demonstrated improved sensitivity and specificity compared with traditional cancer testing approaches. Nanoparticles, nanowires, nanotubes, and nanocantilevers are examples of four nanobiosensor systems that have been used experimentally in the context of detection and diagnosis of prostate, breast, pancreatic, lung, and brain cancers over the past few years. Nanobiosensors will begin to transition into clinically validated tests as experimental and engineering techniques advance. This paper presents examples of some such nanobiosensors for cancer diagnosis and detection.",
keywords = "Cancer detection and diagnosis, Nanobiosensors",
author = "Andrew Gdowski and Ranjan, {Amalendu Prakash} and Anindita Mukerjee and Vishwanatha, {Jamboor K.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-81-322-1777-0_4",
language = "English",
volume = "807",
pages = "33--58",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

Nanobiosensors : Role in cancer detection and diagnosis. / Gdowski, Andrew; Ranjan, Amalendu Prakash; Mukerjee, Anindita; Vishwanatha, Jamboor K.

In: Advances in Experimental Medicine and Biology, Vol. 807, 01.01.2014, p. 33-58.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanobiosensors

T2 - Role in cancer detection and diagnosis

AU - Gdowski, Andrew

AU - Ranjan, Amalendu Prakash

AU - Mukerjee, Anindita

AU - Vishwanatha, Jamboor K.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality. Nanosized components incorporated into existing clinical diagnostic and detection systems as well as novel nanobiosensors have demonstrated improved sensitivity and specificity compared with traditional cancer testing approaches. Nanoparticles, nanowires, nanotubes, and nanocantilevers are examples of four nanobiosensor systems that have been used experimentally in the context of detection and diagnosis of prostate, breast, pancreatic, lung, and brain cancers over the past few years. Nanobiosensors will begin to transition into clinically validated tests as experimental and engineering techniques advance. This paper presents examples of some such nanobiosensors for cancer diagnosis and detection.

AB - The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality. Nanosized components incorporated into existing clinical diagnostic and detection systems as well as novel nanobiosensors have demonstrated improved sensitivity and specificity compared with traditional cancer testing approaches. Nanoparticles, nanowires, nanotubes, and nanocantilevers are examples of four nanobiosensor systems that have been used experimentally in the context of detection and diagnosis of prostate, breast, pancreatic, lung, and brain cancers over the past few years. Nanobiosensors will begin to transition into clinically validated tests as experimental and engineering techniques advance. This paper presents examples of some such nanobiosensors for cancer diagnosis and detection.

KW - Cancer detection and diagnosis

KW - Nanobiosensors

UR - http://www.scopus.com/inward/record.url?scp=84903770675&partnerID=8YFLogxK

U2 - 10.1007/978-81-322-1777-0_4

DO - 10.1007/978-81-322-1777-0_4

M3 - Article

C2 - 24619617

AN - SCOPUS:84903770675

VL - 807

SP - 33

EP - 58

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -